Clinical diagnostics by Gnothis single-molecule DNA sequencing of patient blood samples

Reference number
Coordinator Gnothis AB
Funding from Vinnova SEK 990 000
Project duration May 2018 - June 2020
Status Ongoing
Venture Innovationsprojekt i företag 2018
Call Innovationsprojekt i företag - våren 2018

Purpose and goal

The project has led to a clear next step in introducing a productified version of Gnothis product prototype to clinical clients in locations other than at Karolinska Institutet/Karolinska Sjukhuset. Discussions have been conduced with several university hospitals and other clinical institutions in Sweden and there is a great interest in using Gnothis product.

Expected results and effects

The outcome of the project has led to an increased understanding in the area that the project concerns and in particular has led to that the underlying technology has been further developed to suit the customer´s needs in the best possible way. Also, the project has led to that other potential customers have received information about the technolog aand now has the opportunity to consider purchasing a product version that will be launched as soon as possible.

Planned approach and implementation

The implementation of the project has proceeded essentially as planned. Analyzes have been conducted at Gnothis premises on an instrument prepared for the purpose to enable execution according to schedule, but this has not led to any negative effects.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 19 May 2020

Reference number 2018-01922

Page statistics